Contact this trialFirst, we need to learn more about you.
Enzyme
ADI-PEG 20 + Venetoclax + Azacitidine for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
Miami, Florida
This trial tests a new combination treatment for high-risk AML patients. It uses an enzyme to starve cancer cells and two drugs to make them die and stop growing. The goal is to improve outcomes for patients who may not respond well to standard treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service